← Back to patent-cliff list
Sevelamer Hydrochloride
Tier C — Watch / tradeSevelamer Hydrochloride
Genzyme Corporation
Originator
1998
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Phosphates
Brand：Tasermity, Phosblock, Fosblock, RenaGel
Indications (approved)：Hyperphosphataemia
Regional status
US
Withdrawn
EU
No progress
2004-12-01
China
No progress
2014-04-03
Japan
Approved
2003-01-31
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Sevelamer Hydrochloride?
Approved indications include: Hyperphosphataemia.
When does the Sevelamer Hydrochloride patent expire?
No public expiry year is available for Sevelamer Hydrochloride yet; this page updates once verified.
How do I get a quote for Sevelamer Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27